Transcriptomic characteristics of plasma from Chinese ethnic minority patients with major depressive disorder.

IF 7.5 1区 医学 Q1 PSYCHIATRY
Jun Ye, Jiang Huang, Chongwei Zhou, Zhijin Yuan, Haiping Guan, Zhiyou Long, Haini Chen, Wenfeng Li
{"title":"Transcriptomic characteristics of plasma from Chinese ethnic minority patients with major depressive disorder.","authors":"Jun Ye, Jiang Huang, Chongwei Zhou, Zhijin Yuan, Haiping Guan, Zhiyou Long, Haini Chen, Wenfeng Li","doi":"10.1038/s41398-026-04342-6","DOIUrl":null,"url":null,"abstract":"<p><p>Ethnic and regional disparities have been observed in the diagnosis and treatment of psychiatric disorders. Our previous research revealed metabolic heterogeneity in plasma samples from ethnic minority patients with schizophrenia in Qiandongnan, China. In this study, individuals of Han, Miao, and Dong ethnicities with major depressive disorder (MDD) from Qiandongnan, China, were enrolled. Peripheral blood samples were collected from both the MDD groups of these ethnicities and their corresponding healthy control (HC) groups for transcriptomic analysis. Ethnicity-specific genes and signaling pathways were identified. Specifically, the genes B3GNTL1, DNASE2, and OAS3 may distinguish individuals of Han ethnicity. The gene ELANE may distinguish individuals of Miao ethnicity. The gene SETSIP may distinguish individuals of Dong ethnicity. Transcriptomic heterogeneity in peripheral blood was observed among Han, Miao, and Dong ethnic groups with MDD from Qiandongnan, China. Furthermore trans-ethnically consistent genes and pathways may uncover the core mechanisms of depression. These findings may provide novel insights into diagnosis and treatment strategies for depression.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"16 1","pages":""},"PeriodicalIF":7.5000,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13550567/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-026-04342-6","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0

Abstract

Ethnic and regional disparities have been observed in the diagnosis and treatment of psychiatric disorders. Our previous research revealed metabolic heterogeneity in plasma samples from ethnic minority patients with schizophrenia in Qiandongnan, China. In this study, individuals of Han, Miao, and Dong ethnicities with major depressive disorder (MDD) from Qiandongnan, China, were enrolled. Peripheral blood samples were collected from both the MDD groups of these ethnicities and their corresponding healthy control (HC) groups for transcriptomic analysis. Ethnicity-specific genes and signaling pathways were identified. Specifically, the genes B3GNTL1, DNASE2, and OAS3 may distinguish individuals of Han ethnicity. The gene ELANE may distinguish individuals of Miao ethnicity. The gene SETSIP may distinguish individuals of Dong ethnicity. Transcriptomic heterogeneity in peripheral blood was observed among Han, Miao, and Dong ethnic groups with MDD from Qiandongnan, China. Furthermore trans-ethnically consistent genes and pathways may uncover the core mechanisms of depression. These findings may provide novel insights into diagnosis and treatment strategies for depression.

中国少数民族重度抑郁症患者血浆转录组学特征。
在精神疾病的诊断和治疗方面存在种族和地区差异。我们之前的研究揭示了中国黔东南少数民族精神分裂症患者血浆样本的代谢异质性。本研究以中国黔东南汉族、苗族和侗族重度抑郁症(MDD)患者为研究对象。收集这些种族的MDD组及其相应的健康对照(HC)组的外周血样本进行转录组学分析。确定了种族特异性基因和信号通路。具体来说,基因B3GNTL1、DNASE2和OAS3可能区分了汉族个体。ELANE基因可以区分苗族个体。SETSIP基因可以区分侗族个体。中国黔东南汉族、苗族和侗族重度抑郁症患者外周血转录组异质性研究。此外,跨种族一致的基因和途径可能揭示抑郁症的核心机制。这些发现可能为抑郁症的诊断和治疗策略提供新的见解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
11.50
自引率
2.90%
发文量
484
审稿时长
23 weeks
期刊介绍: Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书